201 related articles for article (PubMed ID: 29427782)
1. Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism.
Zhang R; Zhou J; Ren J; Sun S; Di Y; Wang H; An X; Zhang K; Zhang J; Qian Z; Shi M; Qiao Y; Ren W; Tian Y
Reprod Toxicol; 2018 Apr; 77():53-61. PubMed ID: 29427782
[TBL] [Abstract][Full Text] [Related]
2. Validation of reference genes for quantitative real-time PCR in valproic acid rat models of autism.
Zhou J; Zhang X; Ren J; Wang P; Zhang J; Wei Z; Tian Y
Mol Biol Rep; 2016 Aug; 43(8):837-47. PubMed ID: 27287459
[TBL] [Abstract][Full Text] [Related]
3. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
Schneider T; Przewłocki R
Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991
[TBL] [Abstract][Full Text] [Related]
4. Tactile stimulation improves neuroanatomical pathology but not behavior in rats prenatally exposed to valproic acid.
Raza S; Harker A; Richards S; Kolb B; Gibb R
Behav Brain Res; 2015 Apr; 282():25-36. PubMed ID: 25557797
[TBL] [Abstract][Full Text] [Related]
5. Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.
Codagnone MG; Podestá MF; Uccelli NA; Reinés A
Dev Neurosci; 2015; 37(3):215-31. PubMed ID: 25895486
[TBL] [Abstract][Full Text] [Related]
6. Social behavior, neuroimmune markers and glutamic acid decarboxylase levels in a rat model of valproic acid-induced autism.
Win-Shwe TT; Nway NC; Imai M; Lwin TT; Mar O; Watanabe H
J Toxicol Sci; 2018; 43(11):631-643. PubMed ID: 30404997
[TBL] [Abstract][Full Text] [Related]
7. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
8. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Hara Y; Ago Y; Taruta A; Katashiba K; Hasebe S; Takano E; Onaka Y; Hashimoto H; Matsuda T; Takuma K
Autism Res; 2016 Sep; 9(9):926-39. PubMed ID: 26714434
[TBL] [Abstract][Full Text] [Related]
9. Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism.
Kim JW; Seung H; Kwon KJ; Ko MJ; Lee EJ; Oh HA; Choi CS; Kim KC; Gonzales EL; You JS; Choi DH; Lee J; Han SH; Yang SM; Cheong JH; Shin CY; Bahn GH
PLoS One; 2014; 9(8):e104927. PubMed ID: 25133713
[TBL] [Abstract][Full Text] [Related]
10. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats.
Kim KC; Kim P; Go HS; Choi CS; Yang SI; Cheong JH; Shin CY; Ko KH
Toxicol Lett; 2011 Mar; 201(2):137-42. PubMed ID: 21195144
[TBL] [Abstract][Full Text] [Related]
11. Effects of arginine vasopressin on the transcriptome of prefrontal cortex in autistic rat model.
Zhou B; Yan X; Yang L; Zheng X; Chen Y; Liu Y; Ren Y; Peng J; Zhang Y; Huang J; Tang L; Wen M
J Cell Mol Med; 2022 Nov; 26(21):5493-5505. PubMed ID: 36239083
[TBL] [Abstract][Full Text] [Related]
12. Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.
Hara Y; Takuma K; Takano E; Katashiba K; Taruta A; Higashino K; Hashimoto H; Ago Y; Matsuda T
Behav Brain Res; 2015 Aug; 289():39-47. PubMed ID: 25907743
[TBL] [Abstract][Full Text] [Related]
13. Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally.
Barrett CE; Hennessey TM; Gordon KM; Ryan SJ; McNair ML; Ressler KJ; Rainnie DG
Mol Autism; 2017; 8():42. PubMed ID: 28775827
[TBL] [Abstract][Full Text] [Related]
14. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism.
Schneider T; Turczak J; Przewłocki R
Neuropsychopharmacology; 2006 Jan; 31(1):36-46. PubMed ID: 15920505
[TBL] [Abstract][Full Text] [Related]
15. Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism.
Liu C; Guo Z; Pang J; Zhang Y; Yang Z; Cao J; Zhang T
Behav Brain Res; 2024 Jul; 469():115052. PubMed ID: 38782096
[TBL] [Abstract][Full Text] [Related]
16. RNA-Seq data on prefrontal cortex in valproic acid model of autism and control rats.
Qian Z; Zhang R; Zhou J; Sun S; Di Y; Ren W; Tian Y
Data Brief; 2018 Jun; 18():787-789. PubMed ID: 29900238
[TBL] [Abstract][Full Text] [Related]
17. Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.
Hirsch MM; Deckmann I; Fontes-Dutra M; Bauer-Negrini G; Della-Flora Nunes G; Nunes W; Rabelo B; Riesgo R; Margis R; Bambini-Junior V; Gottfried C
Food Chem Toxicol; 2018 May; 115():336-343. PubMed ID: 29510222
[TBL] [Abstract][Full Text] [Related]
18. Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.
Yamaguchi H; Hara Y; Ago Y; Takano E; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Behav Brain Res; 2017 Aug; 333():67-73. PubMed ID: 28655565
[TBL] [Abstract][Full Text] [Related]
19. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
[TBL] [Abstract][Full Text] [Related]
20. Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism.
Li Z; You M; Che X; Dai Y; Xu Y; Wang Y
Ecotoxicol Environ Saf; 2021 Apr; 212():112000. PubMed ID: 33550075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
